Primary chronic cold agglutinin disease: A population based clinical study of 86 patients

Haematologica

Volumn 91, Issue 4, 2006, Pages 460-466

  Berentsen, Sigbjørn ^a   Ulvestad, Elling ^b   Langholm, Ruth ^b   Beiske, Klaus ^b   Hjorth Hansen, Henrik ^b   Ghanima, Waleed ^b   Sørbø, Jon Hjalmar ^b   Tjønnfjord, Geir E ^b  

^a HAUGESUND HOSPITAL   (Norway)

^b NONE

Author keywords

Anemia; Cold agglutinin; Cold agglutinin disease; Hemolytic; Lymphoproliferative diseases

Indexed keywords

COLD AGGLUTININ; HEMOGLOBIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; PARAPROTEIN; RITUXIMAB;

ADULT; AGED; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; COLD AGGLITININ DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE EXACERBATION; FEMALE; HUMAN; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PREVALENCE; SURVIVAL RATE; SYMPTOMATOLOGY; TREATMENT RESPONSE;

ADULT; AGED; AGED, 80 AND OVER; ANEMIA, HEMOLYTIC, AUTOIMMUNE; CHRONIC DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYELOPROLIFERATIVE DISORDERS; NORWAY; RETROSPECTIVE STUDIES;

EID: 33645960424     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Garratty G, Petz LD, Hoops JK. The correlation of cold agglutinin titrations in saline and albumin with haemolytic anaemia. Br J Haematol 1977;35:587-95.
2. Rosse WF, Adams JP. The variability of hemolysis in the cold agglutinin syndrome. Blood 1980;56:409-16.
3. Ulvestad E, Berentsen S, Bo K, Shammas FV. Clinical immunology of chronic cold agglutinin disease. Eur J Haematol 1999;63:259-66.
4. Berentsen S, Bo K, Shammas FV, Myking AO, Ulvestad E. Chronic cold agglutinin disease of the "idiopathic" type is a premalignant or low-grade malignant lymphoproliferative disease. APMIS 1997;105:354-62.
5. Silberstein LE, Robertson GA, Harris AC, Moreau L, Besa E, Nowell PC. Etiologic aspects of cold agglutinin disease: evidence for cytogenetically defined clones of lymphoid cells and the demonstration that an anti-Pr cold autoantibody is derived from a chromosomally aberrant B cell clone. Blood 1986;67:1705-9.
6. Harboe M, van Furth R, Schubothe H, Lind K, Evans RS. Exclusive occurrence of K chains in isolated cold haemagglutinins. Scand J Haematol 1965; 2:259-66.
7. Harboe M, Deverill J. Immunochemical properties of cold haemagglutinins. Scand J Haematol 1964;61:223-37.
8. Silberstein LE. B-cell origin of cold agglutinins. In: Atassi MZ, ed. Immunobiology of Proteins and Peptides VII. New York: Plenum Press; 1994. p. 193-205.
9. Pascual V, Victor K, Spellerberg M, Hamblin TJ, Stevenson FK, Capra JD. VH restriction among human cold agglutinins. The VH4-21 gene segment is required to encode anti-I and anti-i specificities. J Immunol 1992; 149:2337-44.
10. Berentsen S, Ulvestad E, Gjertsen BT, Hjorth-Hansen H, Langholm R, Knutsen H, et al. Rituximab for primary chronic cold agglutinin disease: a prospective study of 37 courses of therapy in 27 patients. Blood 2004; 103:2925-8.
11. Berger F, Isaacson PG, Piris MA. Lymphoplasmacytic lymphoma/Waldenström macroglobulinemia. In: Jaffe ES, Harris NL, Stein H, Vardiman J, eds. Pathology and genetics of tumours of the haematopoietic and lymphoid tissues. WHO classification of tumours, Vol. 3. Lyon: IARC Press; 2001. p. 132-4.
12. Hadnagy C. Agewise distribution of idiopathic cold agglutinin disease. Z Gerontol 1993;26:199-201.
13. Sokol RJ, Hewitt S, Stamps BK. Auto-immune haemolysis: an 18-year study of 865 cases referred to a regional transfusion centre. Br Med J (Clin Res Ed) 1981;282:2023-7.
14. Dacie J. The auto-immune haemolytic anaemias: introduction. In: Dacie J, ed. The haemolytic anaemias, Vol. 3. London: Churchill Livingstone; 1992. p. 1-5.
15. Genty I, Michel M, Hermine O, Schaeffer A, Godeau B, Rochant H. Characteristics of autoimmune hemolytic anemia in adults: retrospective analysis of 83 cases. [In French]. Rev Med Interne 2002;23:901-9.
16. Schubothe H. The cold hemagglutinin disease. Semin Hematol 1966;3:27-47.
17. Dacie J. Auto-immune haemolytic anaemia (AIHA): cold antibody syndromes I: idiopathic types: clinical presentation and haematological and serological findings. In: Dacie J, ed. The haemolytic anaemias, Vol. 3. London: Churchill Livingstone; 1992. p. 210-39.
18. Dacie J. Auto-immune haemolytic anaemia (AIHA): cold-antibody syndromes II: immunochemistry and specificity of the antibodies; serum complement in auto-immune haemolytic anaemia. In: Dacie J, ed. The haemolytic anaemias, Vol. 3. London: Churchill Livingstone; 1992. p. 240-95.
19. Nydegger UE, Kazatchkine MD, Miescher PA. Immunopathologic and clinical features of hemolytic anemia due to cold agglutinins. Semin Hematol 1991;28:66-77.
20. Rosse WF, Hillmen P, Schreiber AD. Immune-mediated hemolytic anemia. Hematology (Am Soc Hematol Educ Program) 2004;48-62.
21. Rorvik K. The syndrome of high-titre cold haemagglutination; a survey and a case report. Acta Med Scand 1954; 148:299-308.
22. Ulvestad E. Paradoxical haemolysis in a patient with cold agglutinin disease. Eur J Haematol 1998;60:93-100.
23. Ulvestad E, Berentsen S, Mollnes TE. Acute phase haemolysis in chronic cold agglutinin disease. Scand J Immunol 2001;54:239-42.
24. Dacie J. Treatment and prognosis of cold-antibody AIHA. In: Dacie J, ed. The haemolytic anaemias, Vol. 3. London: Churchill Livingstone; 1992. p. 502-8.
25. Worlledge SM, Brain MC, Cooper AC, Hobbs JR, Dacie J. Immmunosuppressive drugs in the treatment of autoimmune haemolytic anaemia. Proc R Soc Med 1968; 61:1312-5.
26. Hippe E, Jensen KB, Olesen H, Lind K, Thomsen PE. Chlorambucil treatment of patients with cold agglutinin syndrome. Blood 1970;35:68-72.
27. Hillen HF, Bakker SJ. Failure of interferon-α-2b therapy in chronic cold agglutinin disease. Eur J Haematol 1994; 53: 242-3.
28. Berentsen S, Tjonnfjord GE, Shammas FV, Bergheim J, Hammerstrom J, Langholm R, et al. No response to cladribine in five patients with chronic cold agglutinin disease. Eur J Haematol 2000;65:88-90.
29. Schollkopf C, Kjeldsen L, Bjerrum OW, Mourits-Andersen HT, Nielsen JL, Christensen BE, et al. Rituximab in chronic cold agglutinin disease: a prospective study of 20 patients. Leuk Lymphoma 2006;47:253-60.
30. Berentsen S, Tjonnfjord GE, Brudevold R, Gjertsen BT, Langholm R, Lokkevik E, et al. Favourable response to therapy with the anti-CD20 monoclonal antibody rituximab in primary chronic cold agglutinin disease. Br J Haematol 2001;115:79-83.
31. Urdal P, Bolann B, Marstein S, Rustad P, Steensland H, Asberg A. Updated reference intervals for clinical chemical components. In Norwegian. Tidsskr Nor Laegeforen 2004;124:1515-7.
32. Stastistics Norway. Population by age and county: absolute figures: 1 January 2005. Accessed on 15-8-2005. http://www.ssb.no/folkemengde_en/tab-2005-03-11-02-en.html. 2005.
33. Stastistics Norway. Population by marital status, sex and age: 1 January 2005. http://www.ssb.no/english/subjects/02/01/10/folkemengde_en/tab-2005-03-11-01-en. html
34. Randall TD, King LB, Corley RB. The biological effects of IgM hexamer formation. Eur J Immunol 1990;20:1971-9.
35. Sokol RJ, Booker DJ, Stamps R, Walewska R. Cold haemagglutinin disease: clinical significance or serum haemolysins. Clin Lab Haematol 2000;22:337-44.
36. Isaksson E, Bjorkholm M, Holm G, Johansson B, Nilsson B, Mellstedt H, et al. Blood clonal B-cell excess in patients with monoclonal gammopathy of undetermined significance (MGUS): association with malignant transformation. Br J Haematol 1996;92:71-6.
37. Owen RG, Treon SP, Al Katib A, Fonseca R, Greipp PR, McMaster ML, et al. Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia. Semin Oncol 2003;30:110-5.
38. Dacie J. Haemolytic anaemias associated with malignant lymphomas other than Hodgkin's disease and chronic lymphocytic leukaemia (CLL). In: Dacie J, ed. The haemolytic anaemias, Vol. 4. London: Churchill Livingstone; 1995. p. 27-40.
39. Crisp D, Pruzanski W. B-cell neoplasms with homogeneous cold-reacting antibodies (cold agglutinins). Am J Med 1982;72:915-22.
40. Michaux L, Dierlamm J, Wlodarska I, Stul M, Bosly A, Delannoy A et al. Trisomy 3 is a consistent chromosome change in malignant lymphoproliferative disorders preceded by cold agglutinin disease. Br J Haematol 1995; 91:421-4.
41. Cesana C, Barbarano L, Miqueleiz S, Lucchesini C, Ricci F, Varettoni M, et al. Clinical characteristics and outcome of immunoglobulin M related disorders. Clin Lymphoma 2005; 5: 261-4.
42. Gehrs BC, Friedberg RC. Autoimmune hemolytic anemia. Am J Hematol 2002;69:258-71.